ARCHIVES

In Brief: Sartorelli Replaces Cole As Director Of Yale Comprehensive Center; NSABP Ends Segmental Trials

This article is from The Cancer Letter archive.

Vol. 10 No. 09 | March 2, 1984

Download PDF Visit The Full Archive

Related Articles

Long-Term Results Find Cisplatin Improves Survival

May 25, 2007

NIH Panel Calls For More Attention to Cancer Pain

July 26, 2002

FDA Authority To Remove Paclitaxel Patent Questioned.

February 9, 2001

In Brief: Carcinogenesis: Does The Promise Justify The Effort? Task Force Attempts To Find Out

September 30, 1977

Pennsylvania Issues RFPs For Cancer Control Program

October 21, 1983

FDA Oncologic Drugs Advisory Committee: Trials In A Small Indication Tell Big Story About Pitfalls of Delaying Progression

April 15, 2011